KRAS mutation, which is more common in right-sided colon cancer (RCC) than in left-sided colon cancer (LCC), is correlated with a negative prognosis in LCC patients but not in RCC patients 5. Here, KRAS is linked to leukoencephalopathy with calcifications and cysts.